Pharma Journalist -

Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a research collaboration agreement with Cedilla Therapeutics, Inc. a private biotechnology company…
Read More...

FibroGen, Inc. and Astellas Pharma Inc.  announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved EVRENZO (roxadustat) for the treatment of anemia of chronic kidney…
Read More...

Haoma Medica announced the completion of a first-in-human trial for NaQuinate, a naphthoquinone carboxylic acid, which is being developed as a novel orally administered therapeutic for…
Read More...

Merck announced that the European Medicines Agency (EMA) has validated for review, the application for tepotinib for the treatment of adult patients with advanced non-small cell lung…
Read More...

Biogen Inc. and Sage Therapeutics, Inc. announced that they have executed a global collaboration and license agreement to jointly develop and commercialize zuranolone (SAGE-217) for…
Read More...

Cantargia AB and BioInvent International AB announced that BioInvent has been contracted as manufacturer of Cantargia's antibody CAN10 in preclinical development for the treatment of…
Read More...

Revance Therapeutics, Inc. a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced that the United States (U.S.) Food and Drug Administration…
Read More...

Celltrion Group announced enrolment completion of 327 patients with mild-to-moderate symptoms of SARS-CoV-2 infection in the global Phase II clinical trial of CT-P59, an anti-COVID-19…
Read More...

SMi Reports: Invitation letter released from the chair of the Parallel Trade virtual conference taking place in March 2021. SMi Group is delighted to present the 15th annual…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that…
Read More...